Journal of Medicinal Chemistry p. 1086 - 1097 (2018)
Update date:2022-08-04
Topics:
Piotrowski, David W.
Futatsugi, Kentaro
Casimiro-Garcia, Agustin
Wei, Liuqing
Sammons, Matthew F.
Herr, Michael
Jiao, Wenhua
Lavergne, Sophie Y.
Coffey, Steven B.
Wright, Stephen W.
Song, Kun
Loria, Paula M.
Banker, Mary Ellen
Petersen, Donna N.
Bauman, Jonathan
A novel series of morpholine-based nonsteroidal mineralocorticoid receptor antagonists is reported. Starting from a pyrrolidine HTS hit 9 that possessed modest potency but excellect selectivity versus related nuclear hormone receptors, a series of libraries led to identification of morpholine lead 10. After further optimization, cis disubstituted morpholine 22 was discovered, which showed a 45-fold boost in binding affinity and corresponding functional potency compared to 13. While 22 had high clearance in rat, it provided sufficient exposure at high doses to favorably assess in vivo efficacy (increased urinary Na+/K+ ratio) and safety. In contrast to rat, the dog and human MetID and PK profiles of 22 were adequate, suggesting that it could be suitable as a potential clinical asset.
View MoreContact:+86-27-85733560
Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
website:http://www.joyochem.com
Contact:0531-82687558, 0531-82687326
Address:Factory Building 11, Jinan Comprehensive free trade zone, Shandong, China
SHENZHEN PENGCHENG REDSTAR INDUSTRY CO.,LTD
Contact:+86-755-82412922
Address:Room 8066, East Block, Square City, Jiabin Road, Luohu District
Zhejiang Linhai Xinhua Chemicals Factory
Contact:0086-13661858911
Address:Xunqiao Development Zone, Linhai, Zhejiang, China
Liao Cheng All Win Chemicals Co.,LTD
Contact:86+0635-2991582
Address:Room 402,Unit 1,No.27 building.Zhong tong shi dai haoyuan,liaocheng city,Shan dong Province.China
Doi:10.1016/0022-328X(91)86057-W
(1991)Doi:10.1039/c2ob06942c
(2012)Doi:10.1016/0022-328X(91)80062-O
(1991)Doi:10.1016/j.poly.2012.02.024
(2012)Doi:10.1002/anie.201109130
(2012)Doi:10.1007/s10600-012-0212-6
(2012)